For the last 5 years he has been involved in consultancy for pharma and biotech industries and embraced the genesis of Flomics as founder and CBO. He is involved in all activities that fall under the umbrella of business strategy and development including business model, funding, stakeholders, market access, IP and regulatory strategy and clinical development, to name a few.

After more than 15 years developing and employing state-of-the-art protocols in high throughput sequencing Esther became a co-founder and CSO at Flomics. There my main tasks are implementing the company’s research strategies and identifying new solutions to meet future needs. Furthermore, she holds a master’s degree in Genetic Counselling as she is deeply committed in transferring the latest advances in basic and applied research to healthcare.